Navigation Links
Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
Date:1/17/2013

o™ studies are expected in late 2013.

For more information regarding the trials, please visit www.clinicaltrials.gov.

About Boehringer Ingelheim in Hepatitis C Virus (HCV)
In partnership with the scientific community, our clinical trial program, HCVerso™, is rigorously designed to find answers to the challenges that HCV patients face, including those who are the most difficult to treat.

Faldaprevir, also known as BI 201335, is an investigational, oral HCV NS3/4A protease inhibitor that may improve viral cure rates as compared to PegIFN/RBV therapy alone, and has completed clinical trials through Phase 2b (SILEN-C studies). Faldaprevir is designed to target the hepatitis C viral reservoir in the liver and inhibit viral replication. The ongoing multi-study Phase 3 STARTVerso™ trial program, evaluating faldaprevir combined with PegIFN/RBV in treatment-naive, treatment-experienced and HIV co-infected patients with chronic genotype-1 HCV, is near clinical completion. BI 207127 is an investigational NS5B non-nucleoside polymerase inhibitor that has shown the potential to eliminate interferon from HCV treatment when combined in a regimen with faldaprevir and RBV. Phase 2 trials of this interferon-free regimen have been completed and Phase 3 HCVerso™ trials investigating this regimen are now underway.

Faldaprevir and BI 207127 are investigational compounds and not approved by the FDA. Their safety and efficacy have not been established.

Hepatitis C is a blood-born infectious disease and a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally. In the United States, an estimated 4.1 million Americans have been infected with HCV, of which approximately 3.2 million have chronic HCV infection. Since 1999 there has been a significant increase in deaths due to ch
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
2. Boehringer Ingelheim Announces Equine Research Awards
3. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
4. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
5. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
6. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
7. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
8. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
9. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
10. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
11. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 genae, a global ... announced today the incorporation of genae UK in London ... has one of the largest medical device markets in the world. ... is projected to increase by a CAGR of 6.0% until 2017. ... to 9.5% of GDP. Despite recessionary pressures, market growth rates over ...
(Date:7/31/2014)... July 31, 2014 Vermillion, Inc. (NASDAQ: VRML), a ... will hold a conference call on Thursday, August 14, 2014, ... second quarter ended June 30, 2014. Financial results will be ... Vermillion,s Chairman, President and CEO James LaFrance ... period. Date: Thursday, August 14, 2014 Time: 4:30 ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 ... developing better, faster and affordable treatments for tuberculosis (TB), ... Senior Vice President, Market Access. Ms. Robertson joins the ... the company,s business in Sub-Saharan Africa and ... will oversee the TB Alliance,s efforts to ensure beneficial ...
Breaking Medicine Technology:genae Opens Offices in London 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3
... 33% 3.5 Years Post Surgery, VIENNA, Va., May ... its cancer drug Multikine(R) was,shown to significantly increase ... of head and neck cancer patients. The data ... International Congress of,the International Association of Oral Oncology ...
... Compliance with Medication Instructions but,Underscore Need for ... Provider Efforts to Control Elevated,Blood Pressure, NEW ... of a survey,conducted by Harris Interactive(R) for ... the American Society of,Hypertension, Inc. (ASH) Twenty-Second ...
Cached Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7
(Date:7/31/2014)... ARLINGTON HEIGHTS, Ill. (August 1, 2014) Women over ... health: an increased risk for obesity, greater struggles against ... outcomes. An article published in the August issue of ... scientific publication of the American College of Allergy, Asthma ... women in treating asthma, and offers practical solutions to ...
(Date:7/31/2014)... The 2013 PolyU TSI hit a record ... in 2012. The index measures inbound tourists’ satisfaction ... into an overall index. The 2013 index indicates ... Hong Kong over time. , The index shows ... in Hong Kong are attractions (79.27) and transportation ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ce-Classes.com has ... education course for healthcare professionals, a Systematic Review ... upon material published in the International Journal of Clinical ... created in response to a need to have accurate ... provide the best treatment possible. The material provides ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has ... sleep apnea (a medical problem where the airway collapses during ... of the rest they need to face their daily challenges. ... 20 million people in the United States alone have sleep ... and of those treated, many cannot tolerate their prescribed medical ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Weblify has finally ... 4 years of development and testing. The result is ... websites in as little as 5 minutes without knowing any ... Weblify review , Shane Michaels, an SEO expert, agrees that ... “I’ve seen a lot of web site builders out ...
Breaking Medicine News(10 mins):Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3
... self-esteem programs receive expansion ... ... recently,awarded $4 million in grants to two nonprofit organizations through its,Highmark ... activity program and a self-esteem initiative, both available,throughout Highmark,s service area., ...
... Despite Scare in ABC,s "Eli,Stone", WHITE PLAINS, N.Y., ... directors of the U.S. Centers for Disease Control,and Prevention ... childhood,vaccines by the suggestion in an upcoming episode of ... -- which is no longer,used in vaccines -- may ...
... But experts question results of small Polish study , , ... a clogged left main coronary artery appeared to give better ... But American experts cast some doubt on the clinical value ... the Medical University of Silesia, compared results of surgery versus ...
... also available in Spanish . The Spanish ... on that using the safety belt on the road can save ... use of such device in the front seats of cars, whereas ... With such a situation on the table, the paper Individual factors ...
... Naturopathic Doctor and Integrative Cancer Treatment Expert,Starts 4-Year ... and Human,Services Secretary Michael Leavitt has appointed Timothy ... the National Advisory Council for Complementary,and Alternative Medicine ... vice president of integrative medicine for Cancer Treatment,Centers ...
... Relationship with NBME and Announces ... Certification Program, TAMPA, Fla., Jan. 29 ... Physicians, Inc. (ABQAURP) is pleased to,announce the organization ... Medical Examiners(R) (NBME(SM)) to oversee and administer ABQAURP,s,professional ...
Cached Medicine News:Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 2Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 3Health News:Childhood Vaccines Save Lives, March Of Dimes Says 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 3Health News:Stents Slightly Better Than Bypass for Blocked Left Coronary Artery 2Health News:Stents Slightly Better Than Bypass for Blocked Left Coronary Artery 3Health News:Using the safety belt in the rear seats of the car reduces death risk by almost a half 2Health News:National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 3
... addition to Laserscopes family of multi-application laser ... from, 1064nm Nd:YAG and 532nm KTP, the ... aesthetic laser market by pushing the envelope ... the safety and reliability record of a ...
... a new, portable, light weight, high power ... cosmetic and plastic surgery, general surgery, ENT ... resurfacing, it is the smallest, yet among ... market. It provides an ideal treatment for ...
... Series, including the Ceralas D and ... soft-tissue applications in medical, dental, and ... water and hemoglobin, the 980 nm ... and provide a bloodless field for ...
... Venus-i™ Laser System is a new, portable, ... with applications in dermatology, cosmetic and plastic ... ideal laser for skin resurfacing, it is ... Erbium:YAG lasers on the market. It provides ...
Medicine Products: